Choice and Medication

At the end of October 2011, the UK MHRA reduced the top doses of citalopram that are recommended.

The Americans have recommended that citalopram is not used at doses above 40mg a day.

Platform 51 (what used to be WYCA) have published a report in July 2011 about the use of antidepressants in women, especially in people taking them for many years.

NICE has reviewed and re-appraised the main drugs used for the treatment of Alzheimer’s disease: donepezil, galantamine, rivastigmine and memantine.

In this video Professor Steve Bazire, MBE, Director, Mistura Enterprise explains the aims of the Choice and medication website.